Breast  ||| S:0 E:7 ||| JJ
cancer  ||| S:7 E:14 ||| NN
screening  ||| S:14 E:24 ||| NN
program  ||| S:24 E:32 ||| NN
in  ||| S:32 E:35 ||| IN
Canada ||| S:35 E:41 ||| NNP
:  ||| S:41 E:43 ||| :
successes  ||| S:43 E:53 ||| NNS
and  ||| S:53 E:57 ||| CC
challenges  ||| S:57 E:68 ||| VBZ
This  ||| S:68 E:73 ||| DT
paper  ||| S:73 E:79 ||| NN
describes  ||| S:79 E:89 ||| VBZ
breast  ||| S:89 E:96 ||| JJ
screening  ||| S:96 E:106 ||| NN
program  ||| S:106 E:114 ||| NN
development  ||| S:114 E:126 ||| NN
in  ||| S:126 E:129 ||| IN
Canada  ||| S:129 E:136 ||| NNP
and  ||| S:136 E:140 ||| CC
the  ||| S:140 E:144 ||| DT
current  ||| S:144 E:152 ||| JJ
status  ||| S:152 E:159 ||| NN
of  ||| S:159 E:162 ||| IN
screening  ||| S:162 E:172 ||| NN
in  ||| S:172 E:175 ||| IN
Canada ||| S:175 E:181 ||| NNP
.  ||| S:181 E:183 ||| .
Programs  ||| S:183 E:192 ||| NNS
have  ||| S:192 E:197 ||| VBP
been  ||| S:197 E:202 ||| VBN
implemented  ||| S:202 E:214 ||| VBN
in  ||| S:214 E:217 ||| IN
most  ||| S:217 E:222 ||| JJS
of  ||| S:222 E:225 ||| IN
Canada ||| S:225 E:231 ||| NNP
,  ||| S:231 E:233 ||| ,
beginning  ||| S:233 E:243 ||| VBG
in  ||| S:243 E:246 ||| IN
the  ||| S:246 E:250 ||| DT
late  ||| S:250 E:255 ||| JJ
1980 ||| S:255 E:259 ||| CD
's ||| S:259 E:261 ||| VBZ
.  ||| S:261 E:263 ||| .
Certain  ||| S:263 E:271 ||| JJ
components  ||| S:271 E:282 ||| NNS
are  ||| S:282 E:286 ||| VBP
common  ||| S:286 E:293 ||| JJ
to  ||| S:293 E:296 ||| TO
all  ||| S:296 E:300 ||| PDT
the  ||| S:300 E:304 ||| DT
programs ||| S:304 E:312 ||| NNS
,  ||| S:312 E:314 ||| ,
but  ||| S:314 E:318 ||| CC
others ||| S:318 E:324 ||| NNS
,  ||| S:324 E:326 ||| ,
such  ||| S:326 E:331 ||| JJ
as  ||| S:331 E:334 ||| IN
personal  ||| S:334 E:343 ||| JJ
invitation  ||| S:343 E:354 ||| NN
letters  ||| S:354 E:362 ||| NNS
for  ||| S:362 E:366 ||| IN
recruitment  ||| S:366 E:378 ||| NN
and  ||| S:378 E:382 ||| CC
clinical  ||| S:382 E:391 ||| JJ
breast  ||| S:391 E:398 ||| NN
examination  ||| S:398 E:410 ||| NN
vary  ||| S:410 E:415 ||| VBP
across  ||| S:415 E:422 ||| IN
the  ||| S:422 E:426 ||| DT
country ||| S:426 E:433 ||| NN
.  ||| S:433 E:435 ||| .
Key  ||| S:435 E:439 ||| JJ
successes  ||| S:439 E:449 ||| NNS
in  ||| S:449 E:452 ||| IN
organized  ||| S:452 E:462 ||| JJ
breast  ||| S:462 E:469 ||| NN
screening  ||| S:469 E:479 ||| NN
in  ||| S:479 E:482 ||| IN
Canada  ||| S:482 E:489 ||| NNP
include  ||| S:489 E:497 ||| VBP
the  ||| S:497 E:501 ||| DT
development  ||| S:501 E:513 ||| NN
of  ||| S:513 E:516 ||| IN
a  ||| S:516 E:518 ||| DT
comprehensive  ||| S:518 E:532 ||| JJ
set  ||| S:532 E:536 ||| NN
of  ||| S:536 E:539 ||| IN
screening  ||| S:539 E:549 ||| JJ
performance  ||| S:549 E:561 ||| NN
indicators ||| S:561 E:571 ||| NNS
,  ||| S:571 E:573 ||| ,
which  ||| S:573 E:579 ||| WDT
are  ||| S:579 E:583 ||| VBP
reported  ||| S:583 E:592 ||| VBN
on  ||| S:592 E:595 ||| IN
regularly ||| S:595 E:604 ||| RB
,  ||| S:604 E:606 ||| ,
and  ||| S:606 E:610 ||| CC
the  ||| S:610 E:614 ||| DT
downward  ||| S:614 E:623 ||| JJ
trend  ||| S:623 E:629 ||| NN
in  ||| S:629 E:632 ||| IN
mortality  ||| S:632 E:642 ||| NN
rates  ||| S:642 E:648 ||| NNS
observed  ||| S:648 E:657 ||| VBD
over  ||| S:657 E:662 ||| IN
the  ||| S:662 E:666 ||| DT
past  ||| S:666 E:671 ||| JJ
20  ||| S:671 E:674 ||| CD
years ||| S:674 E:679 ||| NNS
.  ||| S:679 E:681 ||| .
Challenges  ||| S:681 E:692 ||| NNS
include  ||| S:692 E:700 ||| VBP
the  ||| S:700 E:704 ||| DT
continued  ||| S:704 E:714 ||| JJ
prevalence  ||| S:714 E:725 ||| NN
of  ||| S:725 E:728 ||| IN
opportunistic  ||| S:728 E:742 ||| JJ
screening ||| S:742 E:751 ||| NN
;  ||| S:751 E:753 ||| :
the  ||| S:753 E:757 ||| DT
need  ||| S:757 E:762 ||| NN
to  ||| S:762 E:765 ||| TO
better  ||| S:765 E:772 ||| RB
manage  ||| S:772 E:779 ||| VB
follow-up ||| S:779 E:788 ||| JJ
;  ||| S:788 E:790 ||| :
dealing  ||| S:790 E:798 ||| VBG
with  ||| S:798 E:803 ||| IN
changing  ||| S:803 E:812 ||| VBG
evidence ||| S:812 E:820 ||| NN
;  ||| S:820 E:822 ||| :
and  ||| S:822 E:826 ||| CC
supporting  ||| S:826 E:837 ||| VBG
informed  ||| S:837 E:846 ||| JJ
decision-making  ||| S:846 E:862 ||| NN
about  ||| S:862 E:868 ||| IN
screening ||| S:868 E:877 ||| NN
.  ||| S:877 E:879 ||| .
Approaches  ||| S:879 E:890 ||| NNS
to  ||| S:890 E:893 ||| TO
breast  ||| S:893 E:900 ||| VB
screening  ||| S:900 E:910 ||| NNS
are  ||| S:910 E:914 ||| VBP
dependent  ||| S:914 E:924 ||| JJ
on  ||| S:924 E:927 ||| IN
the  ||| S:927 E:931 ||| DT
health  ||| S:931 E:938 ||| NN
care  ||| S:938 E:943 ||| NN
services  ||| S:943 E:952 ||| NNS
available  ||| S:952 E:962 ||| JJ
in  ||| S:962 E:965 ||| IN
countries ||| S:965 E:974 ||| NNS
,  ||| S:974 E:976 ||| ,
but  ||| S:976 E:980 ||| CC
regardless  ||| S:980 E:991 ||| RB
of  ||| S:991 E:994 ||| IN
the  ||| S:994 E:998 ||| DT
approach ||| S:998 E:1006 ||| NN
,  ||| S:1006 E:1008 ||| ,
good  ||| S:1008 E:1013 ||| JJ
evaluation  ||| S:1013 E:1024 ||| NN
is  ||| S:1024 E:1027 ||| VBZ
necessary ||| S:1027 E:1036 ||| JJ
.  ||| S:1036 E:1038 ||| .
